Dasami Lab Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DEXTROMETHORPHAN HYDROBROMIDE USP, with a corresponding US DMF Number 37412.
Remarkably, this DMF maintains an Active status since its submission on October 31, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 16, 2022, and payment made on November 22, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II